Migrabeta 40mg 10 Tablets

babies: it is not applicable. lactating mother: safe if prescribed by your doctor because human studies have shown limited evidence of no adverse effects to the baby.
pregnancy: consult your doctor because animal and human studies have shown harmful effects on the developing baby. driving: it is unsafe to use while driving as it may cause hallucinations, mental confusion, visual disturbances, and dizziness.
do not drive if these symptoms occur. alcohol: avoid alcohol consumption while taking this medication as it may cause drowsiness and liver damage.
kidney: safe if prescribed by your doctor, and dose adjustment is necessary for patients with kidney disease. liver: this medication should be used with caution in patients with liver disease.
dose adjustment may be necessary for liver disease. .

nausea vomiting diarrhea tiredness weakness arrhythmia raynaud phenomenon.

it works by affecting the nerve impulses in the brain and widening the small blood vessels in the heart, thus preventing heart-related chest pain, decreasing anxiety, and relieving tremors..

if you miss a dose, take it as soon as possible. if it is near the time of the next dose, then skip the missed dose.
take the prescribed dose on your regular time daily. don't double the dose to catch up with the missed dose..

• advice the patient to report the symptoms like difficulty in breathing and wheezing. • tell the patient to report the symptoms like hypoglycemia, bradycardia, and hypotension.
• tell the diabetic patient to monitor blood glucose levels because it may cause hypoglycemia. • do not stop taking this medication unless told by your doctor, as it may cause a sudden rise in hypertension, angina, or myocardial infarction.
• inform your doctor if you notice oedema at the anklet and sudden weight gain. .

contraindicated • migrabeta hydrochloride + thioridazine: concurrent use of migrabeta hydrochloride and thioridazine leads to an increased risk of qt prolongation. major • migrabeta hydrochloride + diltiazem: concurrent use of migrabeta hydrochloride and diltiazem leads to an increased risk of hypotension, bradycardia, av conduction disturbances. moderate • migrabeta hydrochloride + carbamazepine: concurrent use leads to a decrease in migrabeta hydrochloride levels by increasing carbamazepine.
minor • migrabeta hydrochloride + colestipol: concurrent use leads to an increase in colestipol levels by decreasing migrabeta hydrochloride. .